Patents Assigned to Omnio Healer AB
-
Patent number: 10729750Abstract: The present invention relates to the use of plasminogen/plasmin and its derivatives as agents for enhancing host defense against infection or other infectious diseases. The invention also relates to a method for screening of compounds which enhance host defense against infection by evaluating the host defense against bacterial arthritis and spontaneous otitis media in an animal model.Type: GrantFiled: December 9, 2015Date of Patent: August 4, 2020Assignee: Omnio Healer ABInventors: Tor Ny, Jinan Li, Yongzhi Guo
-
Publication number: 20180360931Abstract: The present invention relates to the use of a component of the plasminogen-activating pathway and use of compounds which have the capacity to activate plasminogen directly or via the plasminogen-activating pathway, for prophylaxis, prevention and treatment of periodontal disease including peri-implantitis, healing of periodontal wounds and prompting oral health in human and non-human subjects.Type: ApplicationFiled: August 28, 2018Publication date: December 20, 2018Applicant: Omnio Healer ABInventors: Tor NY, Jinan LI, Yongzhi GUO, Tomas LINDH
-
Patent number: 10086052Abstract: The present invention relates to the use of a component of the plasminogen-activating pathway and use of compounds which have the capacity to activate plasminogen directly or via the plasminogen-activating pathway, for prophylaxis, prevention and treatment of periodontal disease including peri-implantitis, healing of periodontal wounds and prompting oral health in human and non-human subjects.Type: GrantFiled: October 23, 2015Date of Patent: October 2, 2018Assignee: Omnio Healer ABInventors: Tor Ny, Jinan Li, Yongzhi Guo, Tomas Lindh
-
Publication number: 20160243204Abstract: The present invention relates to the use of plasminogen/plasmin and its derivatives as agents for enhancing host defense against infection or other infectious diseases. The invention also relates to a method for screening of compounds which enhance host defense against infection by evaluating the host defense against bacterial arthritis and spontaneous otitis media in an animal model.Type: ApplicationFiled: December 9, 2015Publication date: August 25, 2016Applicant: Omnio Healer ABInventors: Tor NY, Jinan LI, Yongzhi GUO
-
Publication number: 20160184411Abstract: The present invention relates to the use of a component of the plasminogen-activating pathway and use of compounds which have the capacity to activate plasminogen directly or via the plasminogen-activating pathway, for prophylaxis, prevention and treatment of periodontal disease including peri-implantitis, healing of periodontal wounds and prompting oral health in human and non-human subjects.Type: ApplicationFiled: October 23, 2015Publication date: June 30, 2016Applicant: Omnio Healer ABInventors: Tor NY, Jinan LI, Yongzhi GUO, Tomas LINDH
-
Patent number: 8679482Abstract: The present invention relates to the use of plasminogen and plasmin as agents for enhancing healing of tympanic membrane perforations or other wounds, and for reducing scars or necrotic tissue forming during wound healing. The invention also relates to a method for screening of compounds which enhance wound healing by evaluating the healing of tympanic membrane perforations in an animal model.Type: GrantFiled: November 30, 2007Date of Patent: March 25, 2014Assignee: Omnio Healer ABInventors: Tor Ny, Jinan Li, Sten Hellstrom, Per-Olof Eriksson
-
Patent number: 8637010Abstract: The present invention relates to the use of plasminogen and plasmin as agents for enhancing healing of tympanic membrane perforations or other wounds, and for reducing scars or necrotic tissue forming during wound healing. The invention also relates to a method for screening of compounds which enhance wound healing by evaluating the healing of tympanic membrane perforations in an animal model.Type: GrantFiled: October 18, 2005Date of Patent: January 28, 2014Assignee: Omnio Healer ABInventors: Tor Ny, Jinan Li, Sten Hellstrom, Per-Olof Eriksson
-
Publication number: 20130149321Abstract: The present invention relates to the use of plasminogen/plasmin and its derivatives as agents for enhancing host defense against infection or other infectious diseases. The invention also relates to a method for screening of compounds which enhance host defense against infection by evaluating the host defense against bacterial arthritis and spontaneous otitis media in an animal model.Type: ApplicationFiled: November 26, 2012Publication date: June 13, 2013Applicant: OMNIO HEALER ABInventor: OMNIO HEALER AB
-
Patent number: 8318661Abstract: The present invention relates to the use of plasminogen/plasmin and its derivatives as agents for enhancing host defense against infection or other infectious diseases. The invention also relates to a method for screening of compounds which enhance host defense against infection by evaluating the host defense against bacterial arthritis and spontaneous otitis media in an animal model.Type: GrantFiled: August 28, 2007Date of Patent: November 27, 2012Assignee: Omnio Healer ABInventors: Tor Ny, Jinan Li, Yongzhi Guo
-
Publication number: 20110142819Abstract: This invention relates to novel methods of promoting the healing or closure of perforated tympanic membranes or wounds, as well as methods for minimizing scar formation and removing necrotic tissue. In particular the invention relates to the use of components of the plasminogen activating system, especially mini-plasminogen, mini-plasmin, micro-plasminogen, micro-plasmin, delta-plasminogen, and delta-plasmintopromote wound healing processes.Type: ApplicationFiled: January 21, 2009Publication date: June 16, 2011Applicant: Omnio Healer ABInventors: Tor Ny, Jinan Li, Sten Hellstrom, Per-Olof Eriksson
-
Publication number: 20100099600Abstract: The present invention relates to the use of plasminogen/plasmin and its derivatives as agents for enhancing host defense against infection or other infectious diseases. The invention also relates to a method for screening of compounds which enhance host defense against infection by evaluating the host defense against bacterial arthritis and spontaneous otitis media in an animal model.Type: ApplicationFiled: August 28, 2007Publication date: April 22, 2010Applicant: OMNIO HEALER ABInventors: Tor Ny, Jinan Li, Yongzhi Guo
-
Publication number: 20100028321Abstract: The present invention relates to the use of a component of the plasminogen-activating pathway and use of compounds which have the capacity to activate plasminogen directly or via the plasminogen-activating pathway, for prophylaxis, prevention and treatment of periodontal disease including peri-implantitis, healing of periodontal wounds and prompting oral health in human and non-human subjects.Type: ApplicationFiled: August 28, 2007Publication date: February 4, 2010Applicant: OMNIO HEALER ABInventors: Tor Ny, Jinan Li, Yongzhi Guo, Tomas Lindh
-
Publication number: 20080090751Abstract: The present invention relates to the use of plasminogen and plasmin as agents for enhancing healing of tympanic membrane perforations or other wounds, and for reducing scars or necrotic tissue forming during wound healing. The invention also relates to a method for screening of compounds which enhance wound healing by evaluating the healing of tympanic membrane perforations in an animal model.Type: ApplicationFiled: November 30, 2007Publication date: April 17, 2008Applicant: Omnio Healer ABInventors: Tor Ny, Jinan Li, Sten Hellstrom, Per-Olof Eriksson